KH

Karim Hussain

Senior Scientist I - Bioprocess Development at Ingenza Ltd

Karim Hussain is a senior scientist specializing in bioprocess development at Ingenza Ltd since April 2024, with a previous role as a scientist in biology at SOLASTA Bio from October 2022 to March 2024. Prior experience includes serving as a higher scientific officer at The Institute of Cancer Research, where Karim Hussain focused on telomere biology, as well as completing a PhD at the University of St Andrews, studying telomere maintenance in Caenorhabditis elegans. Additional roles span various research and internship positions, including research in environmental microbiology at EPFL, fieldwork on cereal-legume intercropping at The James Hutton Institute, and experiences at diverse medical and academic institutions. Karim Hussain holds a PhD in Biology from the University of St Andrews and a Bachelor's degree in Biochemistry and Molecular Biology from the University of Dundee.

Location

Glasgow, United Kingdom

Links

Previous companies


Org chart

No direct reports

Teams


Offices


Ingenza Ltd

ADVANCED BY NATURE Ingenza is a biotechnology company specialising in the design, development and manufacture of diverse, high-value industrial products and therapeutic-proteins. We exploit synergies between synthetic and evolutionary biology, providing next generation microbial and mammalian manufacturing platforms. What makes Ingenza unique? Dynamic teamwork forged from full integration between the in-house molecular biology, fermentation and chemistry teams, boosted by close ties to UK universities, provides the perfect skillsets to expertly guide you through your project. We can support you at any stage of development, from proof of concept to scaled-up manufacture under GMP conditions. Combining the old and the new Ingenza’s ethos is all about combining the best tried-and-tested traditional methods, the latest breakthroughs and technologies, and a healthy dose of experience and expertise, to bring refreshing innovation to the development of sustainable and cost-competitive biotechnology.


Employees

11-50

Links